Michael Chambers

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Michael Chambers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Chambers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 284K $28.4M $100.13 10 Mar 2025 By Revocable Trust
Sarepta Therapeutics, Inc. Director Common Stock 10.7K $1.07M $100.13 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Options (right to buy) 4.79K 10 Mar 2025 Direct

Insider Reports Filed by Michael Chambers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRPT Sarepta Therapeutics, Inc. 10 Mar 2025 2 $0 4 Director 11 Mar 2025, 20:00
SRPT Sarepta Therapeutics, Inc. 16 Aug 2024 3 $4.96M 4 Director 20 Aug 2024, 08:00
SRPT Sarepta Therapeutics, Inc. 01 Mar 2024 2 $0 4 Director 05 Mar 2024, 20:00
SRPT Sarepta Therapeutics, Inc. 14 Aug 2023 2 $1.09M 4 Director 15 Aug 2023, 09:00
SRPT Sarepta Therapeutics, Inc. 11 Aug 2023 1 $2.56M 4 Director 14 Aug 2023, 09:00
SRPT Sarepta Therapeutics, Inc. 10 Aug 2023 3 $3.7M 4 Director 11 Aug 2023, 07:40
SRPT Sarepta Therapeutics, Inc. 06 Mar 2023 2 $0 4 Director 08 Mar 2023, 19:00
SRPT Sarepta Therapeutics, Inc. 14 Sep 2022 3 $5.96M 4 Director 15 Sep 2022, 08:00
SRPT Sarepta Therapeutics, Inc. 13 Sep 2022 1 $20M 4 Director 14 Sep 2022, 08:00
SRPT Sarepta Therapeutics, Inc. 19 Aug 2022 2 $5M 4 Director 22 Aug 2022, 08:30
SRPT Sarepta Therapeutics, Inc. 02 Jun 2022 2 $0 4 Director 06 Jun 2022, 20:22
SRPT Sarepta Therapeutics, Inc. 02 Jun 2022 0 $0 3 Director 06 Jun 2022, 20:20